Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;16(2):187-191.
doi: 10.5114/aic.2020.96062. Epub 2020 Jun 23.

Short-term healing response after implantation of the thin-strut, fast-releasing sirolimus-eluting biodegradable polymer-coated Alex Plus stent: optical coherence tomography study

Magdalena Dobrolińska  1 , Paweł Gąsior  1 , Tomasz Roleder  2 , Magda Roleder-Dylewska  1 , Grzegorz Smolka  1 , Andrzej Ochała  1 , Elvin Kedhi  1   3 , Wojciech Wojakowski  1
Affiliations

Short-term healing response after implantation of the thin-strut, fast-releasing sirolimus-eluting biodegradable polymer-coated Alex Plus stent: optical coherence tomography study

Magdalena Dobrolińska et al. Postepy Kardiol Interwencyjnej. 2020 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Optical coherence tomography-based stent strut coverage classification: definitely uncovered (A), uncovered fibrin (B), partially covered (C), covered protruding (D), covered embedded (E) and malapposed (F)
Figure 2
Figure 2
Representative optical computed tomography (OCT) imaging before and after Alex Plus implantation as well as at 1-month follow-up. A – Baseline angiography of a patient with stenosis of the right coronary artery (RCA). B – Implantation of Alex Plus stent. C – Angiography at the 1-month follow-up. D – OCT cross-sectional image before Alex Plus implantation. E – OCT cross-sectional image after Alex Plus implantation. F – OCT cross-sectional image at the 1-month follow-up
See this image and copyright information in PMC

References

    1. Orlik B, Buszman PP, Krauze A, et al. A nuclear magnetic resonance spectroscopy as a method for evaluation of in vivo poly-l-lactide biodegradation kinetics from stent-polymer matrices: an experimental study utilizing porcine model of in-stent restenosis. J Cardiovasc Pharmacol Ther. 2016;21:93–6. - PubMed
    1. Vesga B, Hernandez H, Moncada M, et al. Three-month evaluation of strut healing using a novel optical coherence tomography analytical method following bioresorbable polymer everolimus-eluting stent implantation in humans: the TIMELESS study. Coron Artery Dis. 2017;28:126–34. - PubMed
    1. Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet. 2007;370:937–48. - PubMed
    1. Lupi A, Gabrio Secco G, Rognoni A, et al. Meta-analysis of bioabsorbable versus durable polymer drug-eluting stents in 20,005 patients with coronary artery disease: an update. Catheter Cardiovasc Interv. 2014;83:E193–206. - PubMed
    1. Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115:2435–41. - PubMed